Emerging systems biology approaches in nanotoxicology: Towards a mechanism-based understanding of nanomaterial hazard and risk

Toxicology and Applied Pharmacology

Volumn 299, Issue , 2016, Pages 101-111

  Costa, Pedro M ^a   Fadeel, Bengt ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Engineered nanomaterials; Metabolomics; Proteomics; Systems toxicology; Toxicogenomics

Indexed keywords

BIOLOGICAL MARKER; NANOMATERIAL;

ARTICLE; BIOINFORMATICS; ENVIRONMENTAL FACTOR; EPIGENETICS; GENOMICS; HAZARD; METABOLOMICS; NANOTOXICOLOGY; PROTEOMICS; RISK ASSESSMENT; RISK FACTOR; SYSTEMS BIOLOGY; TRANSCRIPTOMICS; ADVERSE EFFECTS; ANIMAL; COMPREHENSION; ENVIRONMENTAL EXPOSURE; GENE EXPRESSION PROFILING; HUMAN; PROCEDURES; TRENDS;

ANIMALS; COMPREHENSION; ENVIRONMENTAL EXPOSURE; GENE EXPRESSION PROFILING; HUMANS; NANOSTRUCTURES; PROTEOMICS; RISK ASSESSMENT; SYSTEMS BIOLOGY;

EID: 84951934257     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2015.12.014     Document Type: Article

References (96)

1. 2 nanoparticles on a living organism: morphological, behavioral, and molecular biology implications. Front. Bioeng. Biotechnol. 2014, 2:37.
2. Ankley G.T., Bennett R.S., Erickson R.J., Hoff D.J., Hornung M.W., Johnson R.D., Mount D.R., Nichols J.W., Russom C.L., Schmieder P.K., Serrrano J.A., Tietge J.E., Villeneuve D.L. Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ. Toxicol. Chem. 2010, 29:730-741.
3. Armand L., Biola-Clier M., Bobyk L., Collin-Faure V., Diemer H., Strub J.-M., Cianferani S., van Dorsselaer A., Herlin-Boime N., Rabilloud T., Carriere M. Molecular responses of alveolar epithelial A549 cells to chronic exposure to titanium dioxide nanoparticles: a proteomic view. J. Proteome 2015, (Aug. 11, Epub ahead of print). 10.1016/j.jprot.2015.08.006.
4. Arora S., Rajwade M., Paknikar K.M. Nanotoxicology and in vitro studies: the need of the hour. Toxicol. Appl. Pharmacol. 2012, 258:151-165.
5. Azuaje F., Devaux Y., Wagner D. Computational biology for cardiovascular biomarker discovery. Brief. Bioinform. 2009, 10:367-377.
6. Bergamaschi E., Magrini A. Biomonitoring. Adverse Effects of Engineered Nanomaterials. Exposure, Toxicology, and Impact on Human Health 2012, 45-62. Academic Press, Elsevier, Amsterdam. B. Fadeel, A. Pietroiusti, A. Shvedova (Eds.).
7. Bhatia S.N., Ingber D.E. Microfluidic organs-on-chips. Nat. Biotechnol. 2014, 32:760-772.
8. Bo Y., Jin C., Liu Y., Yu W., Kang H. Metabolomic analysis on the toxicological effects of TiO[U+2082] nanoparticles in mouse fibroblast cells: from the perspective of perturbations in amino acid metabolism. Toxicol. Mech. Methods 2014, 24:461-469.
9. Böhmert L., Niemann B., Lichtenstein D., Juling S., Lampen A. Molecular mechanism of silver nanoparticles in human intestinal cells. Nanotoxicology 2015, 9:852-860.
10. Braakhuis H.M., Kloet S.K., Kezic S., Kuper F., Park M.V.D.Z., Bellmann S., van der Zande M., Le Gac S., Krystek P., Peters R.J.B., Rietjens M.C.M., Bouwmeester H. Progress and future of in vitro models to study translocation of nanoparticles. Arch. Toxicol. 2015, 89:1469-1495.
11. Brazma A., Hingamp P., Quackenbush J., Sherlock G., Spellman P., Stoeckert C., Aach J., Ansorge W., Ball C.A., Causton H.C., Gaasterland T., Glenisson P., Holstege F.C., Kim I.F., Markowitz V., Matese J.C., Parkinson H., Robinson A., Sarkans U., Schulze-Kremer S., Stewart J., Taylor R., Vilo J., Vingron M. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat. Genet. 2001, 29:365-371.
12. Burgoon L.D. Clearing the standards landscape: the semantics of terminology and their impact on toxicogenomics. Toxicol. Sci. 2007, 99:403-412.
13. Calvano S.E., Xiao W., Richards D.R., Felciano R.M., Baker H.V., Cho R.J., Chen R.O., Brownstein B.H., Cobb J.P., Tschoeke S.K., Miller-Graziano C., Moldawer L.L., Mindrinos M.N., Davis R.W., Tompkins R.G., Lowry S.F. A network-based analysis of systemic inflammation in humans. Nature 2005, 437:1032-1037.
14. Carrola J., Bastos V., Ferreira de Oliveira J.M., Oliveira H., Santos C., Gil A.M., Duarte I.F. Insights into the impact of silver nanoparticles on human keratinocytes metabolism through NMR metabolomics. Arch. Biochem. Biophys. 2015, (Sep. 3, Epub ahead of print). 10.1016/j.abb.2015.08.022.
15. Chatterjee N., Eom H.-J., Choi J. A systems toxicology approach to the surface functionality control of graphene-cell interactions. Biomaterials 2014, 35:1109-1127.
16. Chen M., Zhang M., Borlak J., Tong W. A decade of toxicogenomic research and its contribution to toxicological science. Toxicol. Sci. 2012, 130:217-228.
17. Conde J., Larguinho M., Cordeiro A., Raposo L.R., Costa P.M., Santos S., Diniz M.S., Fernandes A.R., Baptista P.V. Gold-nanobeacons for gene therapy: evaluation of genotoxicity, cell toxicity and proteome profiling analysis. Nanotoxicology 2014, 8:521-532.
18. Docter D., Distler U., Storck W., Kuharev J., Wünsch D., Hahlbrock A., Knauer S.K., Tenzer S., Stauber R.H. Quantitative profiling of the protein coronas that form around nanoparticles. Nat. Protoc. 2014, 9:2030-2044.
19. Docter D., Westmeier D., Markiewicz M., Stolte S., Knauer S.K., Stauber R.H. The nanoparticle biomolecule corona: lessons learned - challenge accepted?. Chem. Soc. Rev. 2015, 44:6094-6121.
20. Donaldson K., Poland C.A. Nanotoxicity: challenging the myth of nano-specific toxicity. Curr. Opin. Biotechnol. 2013, 24:724-734.
21. Donaldson K., Stone V., Tran C.L., Kreyling W., Borm P.J. Nanotoxicology. Occup. Environ. Med. 2004, 61:727-728.
22. Ellinger-Ziegelbauer H., Pauluhn J. Pulmonary toxicity of multi-walled carbon nanotubes (Baytubes®) relative to alpha-quartz following a single 6 h inhalation exposure of rats and a 3 months post-exposure period. Toxicology 2009, 266:16-29.
23. Eom H.J., Chatterjee N., Lee J., Choi J. Integrated mRNA and micro RNA profiling reveals epigenetic mechanism of differential sensitivity of Jurkat T cells to AgNPs and Ag ions. Toxicol. Lett. 2014, 229:311-318.
24. Eom H.-J., Roca C.P., Roh J.-Y., Chatterjee N., Jeong J.-S., Shim I., Kim H.-M., Kim P.-J., Choi K., Giralt F., Choi J. A systems toxicology approach on the mechanism of uptake and toxicity of MWCNT in Caenorhabditis elegans. Chem. Biol. Interact. 2015, 239:153-163.
25. Fadeel B. Systems biology in nanosafety research. Nanomedicine (London) 2015, 10:1039-1041.
26. Fadeel B., Alenius H., Savolainen K. Nanotoxicology. Toxicology 2013, 313:1-2.
27. Fadeel B., Fornara A., Toprak M.S., Bhattacharya K. Keeping it real: the importance of material characterization in nanotoxicology. Biochem. Biophys. Res. Commun. 2015, (Jul 15, Epub ahead of print). 10.1016/j.bbrc.2015.06.178.
28. Feliu N., Fadeel B. Nanotoxicology: no small matter. Nanoscale 2010, 2:2514-2520.
29. Feliu N., Kohonen P., Ji J., Zhang Y., Karlssson H.L., Palmberg L., Nyström A., Fadeel B. Next-generation sequencing reveals low-dose effects of cationic dendrimers in primary human bronchial epithelial cells. ACS Nano 2015, 9:146-163.
30. Fortino V., Kinaret P., Fyhrquist N., Alenius H., Greco D. A robust and accurate method for feature selection and prioritization from multi-class OMICs data. PLoS One 2014, 9:e107801.
31. Fröhlich E., Meindl C., Wagner G., Roblegg E. Use of whole genome expression analysis in the toxicity screening of nanoparticles. Toxicol. Appl. Pharmacol. 2014, 280:272-284.
32. Gallud A., Fadeel B. Keeping it small: towards a molecular definition of nanotoxicology. Eur. J. Nanomed. 2015, 7:143-151.
33. Gao Y., Gopee N.V., Howard P.C., Yu L.-R. Proteomic analysis of early response lymph node proteins in mice treated with titanium dioxide nanoparticles. J. Proteome 2011, 74:2745-2759.
34. Garcia-Contreras R., Sugimoto M., Umemura N., Kaneko M., Hatakeyama Y., Soga T., Tomita M., Scougall-Vilchis R.J., Contreras-Bulnes R., Nakajima H., Sakagami H. Alteration of metabolomic profiles by titanium dioxide nanoparticles in human gingivitis model. Biomaterials 2015, 57:33-40.
35. Griffitt R.J., Lavelle C.M., Kane A.S., Denslow N.D., Barber D.S. Chronic nanoparticulate silver exposure results in tissue accumulation and transcriptomic changes in zebrafish. Aquat. Toxicol. 2013, 130-131:192-200.
36. Halappanavar S., Saber A.T., Decan N., Jensen K.A., Wu D., Jacobsen N.R., Guo C., Rogowski J., Koponen I.K., Levin M., Madsen A.M., Atluri R., Snitka V., Birkedal R.K., Rickerby D., Williams A., Wallin H., Yauk C.L., Vogel U. Transcriptional profiling identifies physicochemical properties of nanomaterials that are determinants of the in vivo pulmonary response. Environ. Mol. Mutagen. 2015, 56:245-264.
37. Haniu H., Matsuda Y., Takeuchi K., Kim Y.A., Hayashi T., Endo M. Proteomics-based safety evaluation of multi-walled carbon nanotubes. Toxicol. Appl. Pharmacol. 2010, 242:256-262.
38. Hartung T. Toxicology for the twenty-first century. Nature 2009, 460:208-212.
39. Higashisaka K., Yoshioka Y., Yamashita K., Morishita Y., Fujimura M., Nabeshi H., Nagano K., Abe Y., Kamada H., Tsunoda S.-I., Yoshikawa T., Itoh N., Tsutsumi Y. Acute phase proteins as biomarkers for predicting the exposure and toxicity of nanomaterials. Biomaterials 2011, 32:3-9.
40. Higashisaka K., Yoshioka Y., Yamashita K., Morishita Y., Pan H., Ogura T., Nagano T., Kunieda A., Nagano K., Abe Y., Kamada H., Tsunoda S., Nabeshi H., Yoshikawa T., Tsutsumi Y. Hemopexin as biomarkers for analyzing the biological responses associated with exposure to silica nanoparticles. Nanoscale Res. Lett. 2012, 7:555.
41. Hilton G.M., Taylor A.J., McClure C.D., Parsons G.N., Bonner J.C., Bereman M.S. Toxicoproteomic analysis of pulmonary carbon nanotube exposure using LC-MS/MS. Toxicology 2015, 329:80-87.
42. Hood L., Heath J.R., Phelps M.E., Lin B. Systems biology and new technologies enable predictive and preventative medicine. Science 2004, 306:640-643.
43. Hu X., Ouyang S., Mu L., An J., Zhou Q. Effects of graphene oxide and oxidized carbon nanotubes on the cellular division, microstructure, uptake, oxidative stress, and metabolic profiles. Environ. Sci. Technol. 2015, 49:10825-10833.
44. Huang D.W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4:44-57.
45. Hussain S.M., Warheit D.B., Ng S.P., Comfort K.K., Grabinski C.M., Braydich-Stolle L.K. At the crossroads of nanotoxicology in vitro: past achievements and current challenges. Toxicol. Sci. 2015, 147:5-16.
46. Ideker T., Galitski T., Hood L. A new approach to decoding life: systems biology. Annu. Rev. Genomics Hum. Genet. 2001, 2:343-372.
47. Ideker T., Thorsson V., Ranish J.A., Christmas R., Buhler J., Eng J.K., Bumgarner R., Goodlett D.R., Aebersold R., Hood L. Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. Science 2001, 292:929-934.
48. Jennings P. The future of in vitro toxicology. Toxicol. in Vitro 2015, 29:1217-1221.
49. Jirtle R.L., Skinner M.K. Environmental epigenomics and disease susceptibility. Nat. Rev. Genet. 2007, 8:253-262.
50. Jovanović B., Ji T., Palić D. Gene expression of zebrafish embryos exposed to titanium dioxide nanoparticles and hydroxylated fullerenes. Ecotoxicol. Environ. Saf. 2011, 74:1518-1525.
51. Kodali V., Littke M.H., Tilton S.C., Teeguarden J.G., Shi L., Frevert C.W., Wang W., Pounds J.G., Thrall B.D. Dysregulation of macrophage activation profiles by engineered nanoparticles. ACS Nano 2013, 7:6997-7010.
52. Kong L., Tuomela S., Hahne L., Ahlfors H., Yli-Harja O., Fadeel B., Lahesmaa R., Autio R. NanoMiner - integrative human transcriptomics data resource for nanoparticle research. PLoS One 2013, 8:e68414.
53. Krug H.F. Nanosafety research-are we on the right track?. Angew. Chem. Int. Ed. Engl. 2014, 53:12304-12319.
54. 1 H-NMR based metabolomics. Ecotoxicol. Environ. Saf. 2015, 120:48-58.
55. Lamb J., Crawford E.D., Peck D., Modell J.W., Blat I.C., Wrobel M.J., Lerner J., Brunet J.P., Subramanian A., Ross K.N., Reich M., Hieronymus H., Wei G., Armstrong S.A., Haggarty S.J., Clemons P.A., Wei R., Carr S.A., Lander E.S., Golub T.R. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 2006, 313:1929-1935.
56. Lucafò M., Gerdol M., Pallavicini A., Pacor S., Zorzet S., Da Ros T., Prato M., Sava G. Profiling the molecular mechanism of fullerene cytotoxicity on tumor cells by RNA-seq. Toxicology 2013, 314:183-192.
57. Lv M., Huang W., Chen Z., Jiang H., Chen J., Tian Y., Zhang Z., Xu F. Metabolomics techniques for nanotoxicity investigations. Bioanalysis 2015, 7:1527-1544.
58. Malysheva A., Lombi E., Voelcker N.H. Bridging the divide between human and environmental nanotoxicology. Nat. Nanotechnol. 2015, 10:835-844.
59. 2 nanoparticle exposure in rats using liquid chromatography tandem mass spectrometry. J. Proteome 2016, 130:85-93.
60. McGinnis S., Madden T.L. BLAST: at the core of a powerful and diverse set of sequence analysis tools. Nucleic Acids Res. 2004, 32(S2):W20-W25.
61. Monopoli M.P., Åberg C., Salvati A., Dawson K.A. Biomolecular coronas provide the biological identity of nanosized materials. Nat. Nanotechnol. 2012, 7:779-786.
62. Moos P.J., Olszewski K., Honeggar M., Cassidy P., Leachman S., Woessner D., Cutler N.S., Verantha J.M. Responses of human cells to ZnO nanoparticles: a gene transcription study. Metallomics 2011, 3:1199-1211.
63. Nel A.E. Implementation of alternative test strategies for the safety assessment of engineered nanomaterials. J. Intern. Med. 2013, 274:561-577.
64. Nel A.E., Mädler L., Velegol D., Xia T., Hoek E.M., Somasundaran P., Klaessig F., Castranova V., Thompson M. Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater. 2009, 8:543-557.
65. Nicholson J.K., Connelly J., Lindon J.C., Holmes E. Metabonomics: a platform for studying drug toxicity and gene function. Nat. Rev. Drug Discov. 2002, 1:153-161.
66. Nik-Zainal S., Kucak J.E., Morganella S., Glodzik D., Alexandrov L.N., Artl V.M., Weninger A., Hollstein M., Stratton M.E., Phillips D.H. The genome as a record of environmental exposure. Mutagenesis 2015, 30:763-770.
67. Palomäki J., Sund J., Vippola M., Kinaret P., Greco D., Savolainen K., Puustinen A., Alenius H. A secretomics analysis reveals major differences in the macrophage responses towards different types of carbon nanotubes. Nanotoxicology 2015, 9:719-728.
68. Pietrovito L., Cano-Cortés V., Gamberi T., Magherini F., Bianchi L., Bini L., Sánchez-Martín, Fasano M., Modesti A. Cellular response to empty and palladium-conjugated amino-polystyrene nanospheres uptake: a proteomic study. Proteomics 2015, 15:34-42.
69. Pisani C., Gaillard J.C., Nouvel V., Odorico M., Armengaud J., Prat O. High-throughput, quantitative assessment of the effects of low-dose silica nanoparticles on lung cells: grasping complex toxicity with a great depth of field. BMC Genomics 2015, 16:315.
70. Ratnasekhar C., Sonane M., Satish A., Mudiam M.K.R. Metabolomics reveals the perturbations in the metabolome of Caenorhabditis elegans exposed to titanium dioxide nanoparticles. Nanotoxicology 2015, 9:994-1004.
71. Robertson D.G., Watkins P.B., Reily M.D. Metabolomics in toxicology: preclinical and clinical applications. Toxicol. Sci. 2011, 120(S1):S146-S170.
72. Robotti E., Manfredi M., Marengo E. Biomarkers discovery through multivariate statistical methods: a review of recently developed methods and applications in proteomics. J. Proteomics Bioinform. 2014, S3:003.
73. 2 particles in the soil nematode Caenorhabditis elegans. Nanotoxicology 2015, 8:502-512.
74. Severson P.L., Vrba L., Stampfer M.R., Futscher B.W. Exome-wide mutation profile in benzo[a]pyrene-derived post-stasis and immortal human mammary epithelial cells. Mutat. Res. 2014, 775-776:48-54.
75. Shim W., Paik M.J., Nguyen D.T., Lee J.K., Lee Y., Kim J.H., Shin E.H., Kang J.S., Jung H.S., Choi S., Park S., Shim J.S., Lee G. Analysis of changes in gene expression and metabolic profiles induced by silica-coated magnetic nanoparticles. ACS Nano 2012, 6:7665-7680.
76. Shvedova A.A., Pietroiusti A., Fadeel B., Kagan V. Mechanisms of carbon nanotube-induced toxicity: focus on oxidative stress. Toxicol. Appl. Pharmacol. 2012, 261:121-133.
77. Shyamasundar S., Ng C.T., Yung L.Y., Dheen S.T., Bay B.H. Epigenetic mechanisms in nanomaterial-induced toxicity. Epigenomics 2015, 7:395-411.
78. Simon D.F., Domingos R.F., Hauser C., Hutchins C.M., Zerges W., Wilkinson K.J. Transcriptome sequencing (RNA-seq) analysis of the effects of metal nanoparticle exposure on the transcriptome of Chlamydomonas reinhardtii. Appl. Environ. Microbiol. 2013, 79:4774-4785.
79. Snyder-Talkington B.N., Dong C., Zhao X., Dymacek J., Porter D.W., Wolfarth M.G., Castranova V., Qian Y., Guo N.L. Multi-walled carbon nanotube-induced gene expression in vitro: concordance with in vivo studies. Toxicology 2015, 328:66-74.
80. Sturla S.J., Boobis A.R., Fitzgerald R.E., Hoeng J., Kavlock R.J., Schirmer K., Whelan M., Wilks M.F., Peitsch M.C. Systems toxicology: from basic research to risk assessment. Chem. Res. Toxicol. 2014, 27:314-329.
81. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., Mesirov J.P. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:15545-15550.
82. Taylor C.F., Paton N.W., Lilley K.S., Binz P.A., Julian R.K., Jones A.R., Zhu W., Apweiler R., Aebersold R., Deutsch E.W., Dunn M.J., Heck A.J., Leitner A., Macht M., Mann M., Martens L., Neubert T.A., Patterson S.D., Ping P., Seymour S.L., Souda P., Tsugita A., Vandekerckhove J., Vondriska T.M., Whitelegge J.P., Wilkins M.R., Xenarios I., Yates J.R., Hermjakob H. The minimum information about a proteomics experiment (MIAPE). Nat. Biotechnol. 2007, 25:887-893.
83. Taylor N.A., Merrifield R., Williams T.D., Chipman J.K., Lead J.R., Viant M.R. Molecular toxicity of cerium oxide nanoparticles to the freshwater alga Chlamydomonas reinhardtii is associated with supra-environmental exposure concentrations. Nanotoxicology 2015, (Sep. 4, Epub ahead of print). 10.3109/17435390.2014.1002868.
84. Teeguarden J.G., Webb-Robertson B.-J., Waters K., Murray A.R., Kisin E.R., Varnum S.M., Jacobs J.M., Pounds J.G., Zanger R.C., Shvedova A.A. Comparative proteomics and pulmonary toxicity of instilled single-walled carbon nanotubes, crocidolite asbestos, and ultrafine carbon black in mice. Toxicol. Sci. 2011, 120:123-135.
85. Tsai Y.Y., Huang Y.H., Chao Y.L., Hu K.Y., Chin L.T., Chou S.H., Hour A.L., Yao Y.D., Tu C.S., Liang Y.J., Tsai C.Y., Wu H.Y., Tan S.W., Chen H.M. Identification of the nanogold particle-induced endoplasmic reticulum stress by omic techniques and systems biology analysis. ACS Nano 2011, 5:9354-9369.
86. Tuomela S., Aution R., Buerki-Thurherr, Arslan O., Kunzmann A., Andersson-Willman B., Wick P., Mathur S., Scheynius A., Krug H., Fadeel B., Lahesmaa Gene expression profiling of immune-competent human cells exposed to engineered zinc oxide or titanium dioxide nanoparticles. PLoS One 2013, 8:e68415.
87. van Aerle R., Lange A., Moorhouse A., Paszkiewicz K., Ball K., Johnston B.D., de Bastos E., Booth T., Tyler C.R., Santos E.M. Molecular mechanisms of toxicity of silver nanoparticles in zebrafish embryos. Environ. Sci. Technol. 2013, 47:8005-8014.
88. van Summeren A., Renes J., van Delft J.H., Kleinjans J.C., Mariman E.C. Proteomics in the search for mechanisms and biomarkers of drug-induced hepatotoxicity. Toxicol. in Vitro 2012, 26:373-385.
89. Verano-Braga T., Methling-Graff R., Wojdyla K., Rogowska-Wresinska A., Brewer J.R., Erdmann H., Kjeldsen F. Insights into the cellular response triggered by silver nanoparticles using quantitative proteomics. ACS Nano 2014, 8:2161-2175.
90. Vogt C., Pernemalm M., Kohonen P., Laurent S., Hultenby K., Vahter M., Lehtiö J., Toprak M.S., Fadeel B. Proteomics analysis reveals distinct corona composition on magnetic nanoparticles with different surface coatings: implications for interactions with primary human macrophages. PLoS One 2015, 10:e0129008.
91. Vrijheid M. The exposome: a new paradigm to study the impact of environment on health. Thorax 2014, 69:876-878.
92. Wang Z., Gerstein M., Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat. Rev. Genet. 2009, 10:57-63.
93. Wild C.P. Complementing the genome with an "exposome": the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol. Biomark. Prev. 2005, 14:1847-1850.
94. Wilmes A., Limonciel A., Aschauer L., Moenks K., Bielow C., Leonard M.O., Hamon J., Carpi D., Ruzek S., Handler A., Schmal O., Herrgen K., Bellwon P., Burek C., Truisi G.L., Hewitt P., Di Consiglio E., Testai E., Blaauboer B.J., Guillou C., Huber C.G., Lukas A., Pfaller W., Mueller S.O., Bois F.Y., Dekant W., Jennings P. Application of integrated transcriptomic, proteomic and metabolomic profiling for the delineation of mechanisms of drug induced cell stress. J. Proteome 2013, 21(79):180-194.
95. Yao Z., Petschnigg J., Ketteler R., Stagljar I. Application guide for omics approaches to cell signaling. Nat. Chem. Biol. 2015, 11:387-397.
96. Zenobi R. Single-cell metabolomics: analytical and biological perspectives. Science 2013, 342:1243259.